These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 16761256

  • 1. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
    Karacorlu M, Arf Karacorlu S, Ozdemir H.
    Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Andrade RE, Muccioli C, Farah ME, Nussenblatt RB, Belfort R.
    Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal triamcinolone acetonide in sympathetic ophthalmia.
    Ozdemir H, Karacorlu M, Karacorlu S.
    Graefes Arch Clin Exp Ophthalmol; 2005 Jul; 243(7):734-6. PubMed ID: 15756580
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Suprachoroidal triamcinolone acetonide injection: a novel therapy for serous retinal detachment due to Vogt-Koyanagi Harada disease.
    Tabl AA, Elsayed MA, Tabl MA.
    Eur J Ophthalmol; 2022 Nov; 32(6):3482-3488. PubMed ID: 35266801
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide.
    Saraiva VS, Sallum JM, Farah ME.
    Ophthalmic Surg Lasers Imaging; 2003 Nov; 34(5):398-400. PubMed ID: 14509465
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal triamcinolone acetonide treatment for serpiginous choroiditis.
    Adigüzel U, Sari A, Ozmen C, Oz O.
    Ocul Immunol Inflamm; 2006 Dec; 14(6):375-8. PubMed ID: 17162609
    [Abstract] [Full Text] [Related]

  • 17. BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis.
    Agarwal A, Freund KB, Kumar A, Aggarwal K, Sharma D, Katoch D, Bansal R, Gupta V, OCTA Study Group.
    Retina; 2021 Apr 01; 41(4):774-783. PubMed ID: 32833410
    [Abstract] [Full Text] [Related]

  • 18. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X, Li J, Hu X, Yu S, Pan J, Tang S.
    Retina; 2011 May 01; 31(5):838-45. PubMed ID: 21293319
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vogt-Koyanagi-Harada disease after stapedotomy.
    Accorinti M, Gilardi M, Nardella C, Amorelli GM, Pesci FR.
    Eur J Ophthalmol; 2015 Oct 21; 25(6):e127-30. PubMed ID: 25982211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.